Infusion suites: the chair is the scarce resource.

3. Three settings, three ways of billing

What a suite is depends on who owns it, and ownership decides the claim.

The home infusion coding standard records that, to close earlier gaps in the code sets, CMS added a modifier effective October 1, 2004 for home infusion services provided in the infusion suite of the infusion therapy provider. A suite owned by a pharmacy therefore bills much like home infusion, with the nursing service coded separately from the per diem. A physician-office center bills like a medical practice, under the practice’s own provider numbers and under the incident-to rules described below.

4. Chairs as the unit of capacity

A suite sells chair time. A chair is occupied for the whole appointment: check-in, access, any premedication, the infusion itself at the rate the order and the drug’s labeling allow, the observation period afterward, and turnover. Two patients cannot hold it at once. The day’s capacity is the number of chairs multiplied by the hours they are staffed, less turnover.

Scheduling is therefore a packing problem. A two-hour biologic and a five-hour immunoglobulin infusion consume different amounts of the same chair, and a first dose needs a longer observation than a maintenance dose. Good suites book by expected chair time derived from the therapy, not by appointment slot, place long infusions early, keep a chair near the nurses’ station for patients who need closer observation, and stagger starts so that nurses are not starting several infusions in the same quarter hour. A cancellation frees a block of time that can only be resold to a patient whose therapy fits it.

5. The suite visit

The visit has a fixed sequence. At check-in the patient’s identity, insurance and authorization are confirmed. The nurse verifies that the order is current and signed, that the drug and dose match it, and that any required laboratory results or pre-infusion checks are on file. The nurse assesses the patient and obtains access, peripherally or through an existing device. Premedications are given if ordered. The drug is administered and the patient monitored at the intervals the order and policy require, then observed for the required period. At discharge the nurse documents the infusion, the patient’s condition, the lot and the amount of drug used and discarded, and gives instructions. The note is reviewed, and where another organization referred the patient it is sent back to them.

6. Buy-and-bill or pharmacy-supplied drug

There are two ways a drug reaches the chair. Under buy-and-bill the practice or facility purchases the drug, holds it in inventory, administers it and bills the payer for the drug and the administration. It carries the cost of inventory, the risk that payment will be less than acquisition cost, and the risk of waste. CMS describes its discarded-drug policy as applying to all providers and suppliers who buy and bill separately payable drugs under Medicare Part B. As CMS states it in 2026, Medicare’s payment limit for most separately payable Part B drugs is the average sales price plus 6 percent, published in a quarterly file.

Under a pharmacy-supplied arrangement a specialty or infusion pharmacy dispenses the drug for the named patient and ships it to the site, and the pharmacy bills the drug to the plan. The site bills only for its services. Plans sometimes require this to control drug cost. It moves the inventory risk off the suite but adds a dependency: the visit cannot happen until the patient’s drug has arrived, been checked in and stored under the pharmacy’s labeling.

7. Professional claims and the code families

A physician-office suite bills on the CMS-1500, the standard claim form for a noninstitutional provider or supplier, maintained by the National Uniform Claim Committee, or on the electronic professional claim. Two code systems meet on it. HCPCS Level II codes, maintained by CMS, identify items not covered by CPT, including drugs; most injectable and infused drugs are reported with “J” codes and billing units. HCPCS Level I is CPT, maintained by the American Medical Association, which identifies the service.

Drug administration is reported with procedure codes that separate hydration, therapeutic infusions and injections, and chemotherapy, and that distinguish an initial service from later ones and infusions by their duration. That is why start and stop times for every drug are a billing fact as well as a clinical one. The rules are detailed, and much revenue in a suite is lost not to denial but to codes that describe less than was done.

8. Incident-to and supervision

In a physician office, nurses’ services and the drugs they give are billed under the physician or practitioner as services incident to the practitioner’s professional service. The conditions are in 42 CFR 410.26. The services must be furnished in a noninstitutional setting to noninstitutional patients, as an integral though incidental part of the practitioner’s diagnosis or treatment, of a kind commonly furnished in an office, by the practitioner or by auxiliary personnel, and in compliance with state law. Auxiliary personnel may be employees, leased employees or independent contractors, and may not be excluded from federal health care programs.

Incident-to services generally require direct supervision. The regulation as currently in force permits the supervising practitioner’s presence, for services without a 10- or 90-day global surgery indicator, through real-time audio and video technology, excluding audio alone. A suite owned by a practice has to be able to show, for any day, who the supervising practitioner was. A suite owned by a pharmacy does not bill incident-to at all, which is one reason the two models are run so differently.

9. Prior authorization and benefit verification

Almost every suite drug needs prior authorization, and the authorization is specific: a drug, sometimes a dose and frequency, a number of administrations, a period, and often a site. Benefit verification establishes whether the drug falls under the medical or the pharmacy benefit, what the patient will owe, and whether the plan requires a particular pharmacy to supply it. Both have to be done before the first appointment and redone before the authorization runs out, a renewal that typically needs fresh clinical documentation from the prescriber. A suite that books a chair without a current authorization is lending a chair for free.

10. Emergency preparedness and staffing

A suite concentrates risk: several patients receive drugs at once, some of them for the first time. Emergency preparedness means standing orders or protocols from a responsible prescriber, emergency medications and equipment checked and in date, staff trained and drilled on the suite’s response, and a defined way to summon emergency services. Staffing is set as a ratio of nurses to occupied chairs that the suite’s policy fixes, adjusted for the acuity of the therapies running and for first doses, with a pharmacist or prescriber reachable as the setting requires. The ratio is a policy decision, and the schedule has to respect it.

11. Accreditation and licensure

The Accreditation Commission for Health Care offers an Ambulatory Infusion Center accreditation, describing such centers as centralized locations where a patient receives infusion therapy administered by appropriate clinical personnel. The National Infusion Center Association, an ANSI-accredited standards developer, publishes Standards of Excellence for Ambulatory Infusion Centers, which it describes as American National Standards, and runs an accreditation program on them. A pharmacy-owned suite is often surveyed as part of its home infusion accreditation under supplemental standards.

State licensure follows ownership. A pharmacy-owned suite usually operates under the pharmacy’s board of pharmacy license, and some states require a separate permit or registration for the site where drugs are administered. A physician-owned center operates under the practice and the medical board’s rules, sometimes with a separate clinic or facility license. A hospital department sits under the hospital’s license. The nurses are licensed by the board of nursing in either case. An operator opening a suite in a new state has to check each of those doors.

12. Inventory, wastage and discarded drug

Suite drugs are expensive and most come in single-dose vials whose labeled amount rarely matches the patient’s dose exactly. Under Medicare’s discarded-drug policy, providers and suppliers have been required since January 1, 2017 to report the JW modifier on claims for separately payable Part B drugs from single-dose containers when an amount was discarded, and since no later than July 1, 2023 to report the JZ modifier when nothing was discarded. CMS states that from October 1, 2023 claims that do not use the modifiers as appropriate may be returned as unprocessable. The discarded amount must be documented in the medical record. The modifier data also feed the discarded-drug refunds that manufacturers owe CMS under the Infrastructure Investment and Jobs Act.

The operating consequence is that every administration has to record what was opened, what was given and what was discarded, by lot, and the claim has to agree with that record. For a buy-and-bill suite the same numbers reconcile inventory: what was bought, what was used, what was wasted and what is still on the shelf.